Skip to content
★ Sign in to follow
HP

Hugo Petit

Lipigon Phartmaceuticals AB
Total declarations
2
Company
1
▲ Purchases (2 ops.)
€2,760
▼ Sales (0 ops.)
—

Latest filing published 26 Apr 2024 for Lipigon Phartmaceuticals AB, €1,351.

Filing timeline

BuySale
Hugo Petit

Insider track record

Disclosed buys
2
Disclosed sells
0
Signal history

No signal scores available.

Closed purchases

Market purchases
2

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

Hugo Petit: trading record in brief

All filings by Hugo Petit on record concern Lipigon Phartmaceuticals AB. Over a trading history stretching from 21 March 2024 to 26 April 2024, the count stands at 2 filings.

Every open-market trade on record is a purchase: 2 purchases worth €2,760, and no sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price.

Most recently, on 26 April 2024, the filings show an open-market purchase worth €1,351 in Lipigon Phartmaceuticals AB. Source: insider filings from Finansinspektionen. Past trades are no guide to future returns.

Companies and markets linked to Hugo Petit

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations2 total
  • ▲
    Ekonomichef/finanschef/finansdirektörExecutivesLipigon Phartmaceuticals AB
    15,780 SEK0FI-SE
    263,000 shares@ SEK 0.0648.9% of flowTeckningsoptionFI:csv-6f16bf8d0d7fdf5802e4
    Canonical exit: 25 Jul 2024 (T+90)
  • ▲
    Ekonomichef/finanschef/finansdirektörExecutivesLipigon Phartmaceuticals AB
    16,000 SEK0FI-SE
    200,000 shares@ SEK 0.0851.1% of flowTeckningsoptionISIN SE0019914102FI:csv-635600198a9e13a43966
    Canonical exit: 19 Jun 2024 (T+90)

2 of 2 declarations